BillionToOne BLLN 深 沪
等待开盘 05-20 09:30:00 美东时间
82.29
-3.830
-4.45%
华盛通- 最 高87.17
- 今 开85.63
- 成交量 47.65万股
- 最 低 82.145
- 昨 收 86.12
- 总市值 37.69亿
- 52周最高 138.70
- 市盈率 静 1291.84
- 换手率 1.04%
- 52周最低 61.96
- 委 比 79.10%
- 总股本 4580.48万
- 历史最高 138.70
- 量 比 0.58
- 振 幅 5.83%
- 历史最低 61.96
- 每 手 1
- 风险率 12.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jim Cramer: Design Therapeutics Is 'Pure Spec,' Buy This Health Care Stock
Cramer likes Silicon Motion, whose shares fell 2.2% to settle at $263.85 on Thursday. Wynn shares declined 0.8% to close at $95.43.
05-15 19:46
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
BillionToOne shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates.
BillionToOne shares are trading higher after the company reported better-than-e...
05-07 20:27
BTIG Maintains Buy on BillionToOne, Lowers Price Target to $130
BTIG analyst Mark Massaro maintains BillionToOne (NASDAQ:BLLN) with a Buy and lowers the price target from $140 to $130.
05-07 18:53
BillionToOne Earnings Call Signals Profitable Hyper-Growth
BillionToOne, Inc. Class A (($BLLN)) has held its Q1 earnings call. Read on for...
05-07 09:16
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Joby Aviation Is 'Too Risky,' But This Industrial Stock Is A 'Winner': Jim Cramer
Cramer shared his thoughts on various stocks, calling Joby Aviation too risky, BillionToOne a winner, Boston Scientific caught in competition, Rocket Lab a winner, and Pinnacle West Capital a good company. He also endorsed Intuitive Machines as a speculative stock.
04-28 19:43
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Guggenheim Maintains Buy on BillionToOne, Lowers Price Target to $100
Guggenheim analyst Subbu Nambi maintains BillionToOne (NASDAQ:BLLN) with a Buy and lowers the price target from $120 to $100.
03-30 23:28
